Completed NA INTERVENTIONAL 1-arm NCT04721145

CGM Use in Poorly Controlled Youth With Type 1 Diabetes (IMPaCT)

IMPaCT: IMPlementing Continuous Glucose Monitoring in High-risk, Poorly Controlled Children With Type 1 Diabetes

Sponsor: DexCom, Inc.

Conditions High Blood Sugar Hypoglycemia Type 1 Diabetes

Interventions Dexcom G6 Continuous Glucose Monitor

Updated 9 times since 2021 Last updated: Jul 17, 2023 Started: Jan 25, 2021 Primary completion: Jun 28, 2022 Completion: Jun 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates High Blood Sugar and Hypoglycemia and is currently completed. DexCom, Inc. leads this study, which shows 9 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2023 — Jul 2024 [monthly]

Completed NA
Sep 2022 — Sep 2023 [monthly]

Completed NA
Jul 2022 — Sep 2022 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 4 earlier versions

Jun 2022 — Jul 2022 [monthly]

Recruiting NA
Mar 2022 — Jun 2022 [monthly]

Recruiting NA
Mar 2021 — Mar 2022 [monthly]

Recruiting NA
Feb 2021 — Mar 2021 [monthly]

Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DexCom, Inc.
Johns Hopkins University

Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States